Skip to content
10-Q

Quarterly Report

Nuvectis Pharma, Inc. NVCT

0001558370-25-010203

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 25.46M sh
Shares Diluted Q2 2025 · Jun 30, 2025 21.37M sh
Shares Diluted Q2 2025 · Jun 30, 2025 20.66M sh
Shares Diluted Q2 2025 · Jun 30, 2024 16.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 16.73M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$7.54M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7.38M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26.79M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $18.53M
Stockholders Equity Q2 2025 · Jun 30, 2025 $16.87M
Stockholders Equity Q2 2025 · Mar 31, 2025 $20.95M
Stockholders Equity Q2 2025 · Dec 31, 2024 $9.71M
Stockholders Equity Q2 2025 · Jun 30, 2024 $12.53M
Stockholders Equity Q2 2025 · Mar 31, 2024 $14.02M
Stockholders Equity Q2 2025 · Dec 31, 2023 $12.2M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.14M
Current Liabilities Q2 2025 · Dec 31, 2024 $8.89M
Total Liabilities Q2 2025 · Jun 30, 2025 $10.14M
Total Liabilities Q2 2025 · Dec 31, 2024 $8.89M
Current Assets Q2 2025 · Jun 30, 2025 $27.01M
Current Assets Q2 2025 · Dec 31, 2024 $18.61M
Total Assets Q2 2025 · Jun 30, 2025 $27.01M
Total Assets Q2 2025 · Dec 31, 2024 $18.61M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.30
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.56
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.51
Eps Basic Q2 2025 · Jun 30, 2025 −$0.30
Eps Basic Q2 2025 · Jun 30, 2025 −$0.56
Eps Basic Q2 2025 · Jun 30, 2024 −$0.26
Eps Basic Q2 2025 · Jun 30, 2024 −$0.51
Sga Expense Q2 2025 · Jun 30, 2025 $2.98M
Sga Expense Q2 2025 · Jun 30, 2025 $4.87M
Sga Expense Q2 2025 · Jun 30, 2024 $1.7M
Sga Expense Q2 2025 · Jun 30, 2024 $3.44M
Rd Expense Q2 2025 · Jun 30, 2025 $3.61M
Rd Expense Q2 2025 · Jun 30, 2025 $7.29M
Rd Expense Q2 2025 · Jun 30, 2024 $2.94M
Rd Expense Q2 2025 · Jun 30, 2024 $5.6M
Net Income Q2 2025 · Jun 30, 2025 −$6.33M
Net Income Q2 2025 · Jun 30, 2025 −$11.67M
Net Income Q2 2025 · Mar 31, 2025 −$5.33M
Net Income Q2 2025 · Jun 30, 2024 −$4.43M
Net Income Q2 2025 · Jun 30, 2024 −$8.6M
Net Income Q2 2025 · Mar 31, 2024 −$4.17M
Operating Income Q2 2025 · Jun 30, 2025 −$6.6M
Operating Income Q2 2025 · Jun 30, 2025 −$12.16M
Operating Income Q2 2025 · Jun 30, 2024 −$4.64M
Operating Income Q2 2025 · Jun 30, 2024 −$9.04M